Q32 Bio Inc. (QTTB) › Operating Cash FlowQ32 Bio Inc. (QTTB) — Operating Cash FlowAnnual figures by period end, from SEC filings.2017-12-31: $6.48M2018-12-31: -$42.56M2019-12-31: -$91.36M2020-12-31: -$94.33M2021-12-31: -$109.75M2022-12-31: -$113.66M2023-12-31: -$18.68M2024-12-31: -$67.72M2025-12-31: -$33.54M-$33.54M2017-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$33.54M—2026-03-10From 2025-01-012024-12-31-$67.72M—2026-03-10From 2024-01-012023-12-31-$18.68M—2025-03-11From 2023-01-012022-12-31-$113.66M—2024-03-13From 2022-01-012021-12-31-$109.75M—2023-03-09From 2021-01-012020-12-31-$94.33M—2022-03-23From 2020-01-012019-12-31-$91.36M—2021-03-11From 2019-01-012018-12-31-$42.56M-756.9%2020-03-12From 2018-01-012017-12-31$6.48M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)